Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Index by author

October 01, 2013; Volume 65,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

C

  1. Chabner, Bruce

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807
  2. Chen, Xiaoyuan

    1. You have access
      Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
      Orit Jacobson and Xiaoyuan Chen
      Michael G. Rosenblum, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1214-1256; DOI: https://doi.org/10.1124/pr.113.007625
  3. Cheng, Yan

    1. You have access
      Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
      Yan Cheng, Xingcong Ren, William N. Hait and Jin-Ming Yang
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1162-1197; DOI: https://doi.org/10.1124/pr.112.007120
  4. Christopoulos, Arthur

    1. You have access
      Cofactoring and Dimerization of Proteinase-Activated Receptors
      Huilan Lin, Allen P. Liu, Thomas H. Smith and JoAnn Trejo
      Arthur Christopoulos, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1198-1213; DOI: https://doi.org/10.1124/pr.111.004747
  5. Clark, Jeffrey

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807

G

  1. Gainor, Justin

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807
  2. Gillies, Glenda E.

    1. You have access
      Insights into Rapid Modulation of Neuroplasticity by Brain Estrogens
      Deepak P. Srivastava, Kevin M. Woolfrey and Peter Penzes
      Glenda E. Gillies, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1318-1350; DOI: https://doi.org/10.1124/pr.111.005272

H

  1. Hait, William N.

    1. You have access
      Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
      Yan Cheng, Xingcong Ren, William N. Hait and Jin-Ming Yang
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1162-1197; DOI: https://doi.org/10.1124/pr.112.007120

I

  1. Insel, Paul A.

    1. You have access
      Aryl Hydrocarbon Receptor Control of Adaptive Immunity
      Francisco J. Quintana and David H. Sherr
      Paul A. Insel, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1148-1161; DOI: https://doi.org/10.1124/pr.113.007823
  2. Izar, Benjamin

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807

J

  1. Jacobson, Orit

    1. You have access
      Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
      Orit Jacobson and Xiaoyuan Chen
      Michael G. Rosenblum, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1214-1256; DOI: https://doi.org/10.1124/pr.113.007625

L

  1. Lin, Huilan

    1. You have access
      Cofactoring and Dimerization of Proteinase-Activated Receptors
      Huilan Lin, Allen P. Liu, Thomas H. Smith and JoAnn Trejo
      Arthur Christopoulos, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1198-1213; DOI: https://doi.org/10.1124/pr.111.004747
  2. Liu, Allen P.

    1. You have access
      Cofactoring and Dimerization of Proteinase-Activated Receptors
      Huilan Lin, Allen P. Liu, Thomas H. Smith and JoAnn Trejo
      Arthur Christopoulos, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1198-1213; DOI: https://doi.org/10.1124/pr.111.004747
  3. Longo, Dan L.

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807

M

  1. Ma, Qiang

    1. You have access
      Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
      Yan Cheng, Xingcong Ren, William N. Hait and Jin-Ming Yang
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1162-1197; DOI: https://doi.org/10.1124/pr.112.007120

O

  1. Ohlstein, Eliot H.

    1. You have access
      Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
      D. F. Woodward, J. W. Wang and N. J. Poloso
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1135-1147; DOI: https://doi.org/10.1124/pr.112.007088

P

  1. Pan, Ying-Xian

    1. You have access
      Mu Opioids and Their Receptors: Evolution of a Concept
      Gavril W. Pasternak and Ying-Xian Pan
      David R. Sibley, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1257-1317; DOI: https://doi.org/10.1124/pr.112.007138
  2. Pasternak, Gavril W.

    1. You have access
      Mu Opioids and Their Receptors: Evolution of a Concept
      Gavril W. Pasternak and Ying-Xian Pan
      David R. Sibley, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1257-1317; DOI: https://doi.org/10.1124/pr.112.007138
  3. Penzes, Peter

    1. You have access
      Insights into Rapid Modulation of Neuroplasticity by Brain Estrogens
      Deepak P. Srivastava, Kevin M. Woolfrey and Peter Penzes
      Glenda E. Gillies, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1318-1350; DOI: https://doi.org/10.1124/pr.111.005272
  4. Poloso, N. J.

    1. You have access
      Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
      D. F. Woodward, J. W. Wang and N. J. Poloso
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1135-1147; DOI: https://doi.org/10.1124/pr.112.007088

Q

  1. Quintana, Francisco J.

    1. You have access
      Aryl Hydrocarbon Receptor Control of Adaptive Immunity
      Francisco J. Quintana and David H. Sherr
      Paul A. Insel, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1148-1161; DOI: https://doi.org/10.1124/pr.113.007823

R

  1. Ren, Xingcong

    1. You have access
      Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
      Yan Cheng, Xingcong Ren, William N. Hait and Jin-Ming Yang
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1162-1197; DOI: https://doi.org/10.1124/pr.112.007120
  2. Rosenblum, Michael G.

    1. You have access
      Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
      Orit Jacobson and Xiaoyuan Chen
      Michael G. Rosenblum, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1214-1256; DOI: https://doi.org/10.1124/pr.113.007625
  3. Rotow, Julia

    1. You have access
      Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer
      Benjamin Izar, Julia Rotow, Justin Gainor, Jeffrey Clark and Bruce Chabner
      Dan L. Longo, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1351-1395; DOI: https://doi.org/10.1124/pr.113.007807

S

  1. Sherr, David H.

    1. You have access
      Aryl Hydrocarbon Receptor Control of Adaptive Immunity
      Francisco J. Quintana and David H. Sherr
      Paul A. Insel, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1148-1161; DOI: https://doi.org/10.1124/pr.113.007823
  2. Sibley, David R.

    1. You have access
      Mu Opioids and Their Receptors: Evolution of a Concept
      Gavril W. Pasternak and Ying-Xian Pan
      David R. Sibley, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1257-1317; DOI: https://doi.org/10.1124/pr.112.007138
  3. Smith, Thomas H.

    1. You have access
      Cofactoring and Dimerization of Proteinase-Activated Receptors
      Huilan Lin, Allen P. Liu, Thomas H. Smith and JoAnn Trejo
      Arthur Christopoulos, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1198-1213; DOI: https://doi.org/10.1124/pr.111.004747
  4. Srivastava, Deepak P.

    1. You have access
      Insights into Rapid Modulation of Neuroplasticity by Brain Estrogens
      Deepak P. Srivastava, Kevin M. Woolfrey and Peter Penzes
      Glenda E. Gillies, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1318-1350; DOI: https://doi.org/10.1124/pr.111.005272

T

  1. Trejo, JoAnn

    1. You have access
      Cofactoring and Dimerization of Proteinase-Activated Receptors
      Huilan Lin, Allen P. Liu, Thomas H. Smith and JoAnn Trejo
      Arthur Christopoulos, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1198-1213; DOI: https://doi.org/10.1124/pr.111.004747

W

  1. Wang, J. W.

    1. You have access
      Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
      D. F. Woodward, J. W. Wang and N. J. Poloso
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1135-1147; DOI: https://doi.org/10.1124/pr.112.007088
  2. Woodward, D. F.

    1. You have access
      Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
      D. F. Woodward, J. W. Wang and N. J. Poloso
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1135-1147; DOI: https://doi.org/10.1124/pr.112.007088
  3. Woolfrey, Kevin M.

    1. You have access
      Insights into Rapid Modulation of Neuroplasticity by Brain Estrogens
      Deepak P. Srivastava, Kevin M. Woolfrey and Peter Penzes
      Glenda E. Gillies, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1318-1350; DOI: https://doi.org/10.1124/pr.111.005272

Y

  1. Yang, Jin-Ming

    1. You have access
      Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
      Yan Cheng, Xingcong Ren, William N. Hait and Jin-Ming Yang
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews October 2013, 65 (4) 1162-1197; DOI: https://doi.org/10.1124/pr.112.007120
Back to top
PreviousNext

In this issue

Pharmacological Reviews: 65 (4)
Pharmacological Reviews
Vol. 65, Issue 4
1 Oct 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics